Berberine
Also known as: berberine chloride
Classification
Supplement
Regulatory Status
dietary ingredient / not FDA-approved as a drug for disease treatment
Sources
3
Review
n/a
Overview
Berberine is represented by its commonly described plant alkaloid ampk modulator mechanism. This conservative launch record supports search and overlap detection, not medical recommendation.
Evidence and limitations
Human/preclinical evidence breakdown is not available in this record.
Pathways
Benefits
People look up berberine for studied effects on glycemic and lipid markers; evidence is mixed-to-moderate across trials and it is not an approved diabetes drug.
Interactions & cautions
Flagged in source data
Drug interactions
insulin and other glucose-lowering drugs — Additive glucose-lowering and hypoglycemia risk. (high)
CYP3A4 and P-glycoprotein substrates (for example some statins, immunosuppressants, other narrow-therapeutic-index drugs) — Berberine can alter exposure of substrates in interaction studies/experimental data; clinician/pharmacist review required. (high)
These are observational flags for review, not individualized instructions.
Sources
Educational reference only — not medical advice.
What people report (anecdote)
CLINICAL DATA (from trials)
Adverse events:
None recorded in our sources.
Effects measured:
Human trials: none found.
ANECDOTE
What people report: anecdote, not evidence
Loading…
Submit a claim you saw